Trial intelligence / Profile preview

Sulodexide in Diabetic Non-Proliferative Retinopathy

NCT01295775Phase 2Completed

Sponsor
Ajou University School of Medicine
Start
Feb 2009
Primary completion
Apr 2011
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sulodexide in diabetic retinopathy (DR), sponsored by Ajou University School of Medicine. Started Feb 2009; status: completed.

02

Drugs

sulodexide
03

Conditions

diabetic retinopathy (DR)

Beyond the preview

Go deeper on NCT01295775.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01295775.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call